100% Quality Guarantee
PhD-Level Technical Support
Key Features

Human IL29 (Interleukin 29) ELISA (Small Sample Volume) (AEKE06059)

SKU AEKE06059
Reactivity Human
Detection Method Sandwich
Sensitivity 2.6 pg/mL
Standard 500 pg/mL
Range 7.82-500 pg/mL
€649 - €5,841

Request a formal quotation

A PDF quote with its own quote number, ready for your purchasing office to raise a PO against. Back within 4 working hours, from a PhD scientist — not an autoresponder.

  • PO-ready PDFQuote number, VAT, Incoterms
  • Volume pricing appliedDiscounts from 2 kits up
  • Valid 30 daysPrices held while you get sign-off
Anything we should know? optional

No account needed. We use your details only to prepare and send this quote. If it's urgent, say so in the box and we'll come back the same working day.

Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

Human IL29 ELISA Kit (Small Sample Volume)

Human IL29 ELISA kits are used to detect Interleukin 29 (IL29) in serum, plasma, tissue homogenates, cell lysates, cell culture supernatants and other biological samples. IL29, also known as interferon lambda 1 (IFNL1), is a type III interferon and class II cytokine with antiviral, antitumour and immunomodulatory activities, produced by cells such as dendritic cells and epithelial cells during viral infection. It engages a heterodimeric receptor of IL10RB and IFNLR1, triggering the JAK/STAT pathway and the expression of interferon-stimulated genes that confer an antiviral state. Since IFNLR1 is largely confined to epithelial cells, IL29 acts mostly on mucosal and barrier tissues, where it provides a first line of defence, and it raises MHC class I expression. Its concentration may be elevated in viral infections and has been reported to change in autoimmune conditions, and it is investigated as an antiviral therapeutic candidate.

system_update_altDatasheetsystem_update_altMSDS
View AllClose

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose